Assessment accuracy of core needle biopsy for hormone receptors in breast cancer: a meta-analysis Shichao LiXinhua YangJun Jiang Review 22 April 2012 Pages: 325 - 334
Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis Fausto PetrelliKaren BorgonovoSandro Barni Review 12 June 2012 Pages: 335 - 346
Risk of rash with the anti-HER2 dimerization antibody pertuzumab: a meta-analysis Aaron M. DruckerShenhong WuMario E. Lacouture Review 11 July 2012 Pages: 347 - 354
Systemic therapy options in BRCA mutation-associated breast cancer Soley BayraktarStefan Glück Review 12 July 2012 Pages: 355 - 366
Physical activity and mammographic breast density: a systematic review Lusine YaghjyanGraham A. ColditzKathleen Wolin Review 20 July 2012 Pages: 367 - 380
The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer Kristin JonsdottirHui ZhangJan P. A. Baak Preclinical Study 08 July 2012 Pages: 381 - 390
Beyond radiation therapy: photodynamic therapy maintains structural integrity of irradiated healthy and metastatically involved vertebrae in a pre-clinical in vivo model Victor C. K. LoMargarete K. AkensCari M. Whyne Preclinical Study 12 July 2012 Pages: 391 - 401
Loss of Dicer expression is associated with breast cancer progression and recurrence Sarkawt M. KhoshnawEmad A. RakhaAndrew R. Green Preclinical Study 21 July 2012 Pages: 403 - 413
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures Peter KabosJessica Finlay-SchultzCarol A. Sartorius Preclinical Study 24 July 2012 Pages: 415 - 432
Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells Warren FiskusStacey L. HembruffKapil N. Bhalla Preclinical study 24 July 2012 Pages: 433 - 444
Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion Tao ZhangJingjie LiZhengfang Yi Preclinical Study 28 July 2012 Pages: 445 - 458
Peritumoral FOXP3+ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3+ regulatory T cell is prognostic predictor of breast cancer patients Fangfang LiuYaqing LiLi Fu Preclinical Study 29 July 2012 Pages: 459 - 467
Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression Ben A. HallTae Yeon KimSuzanne D. Conzen Preclinical study 29 July 2012 Pages: 469 - 479
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer Johanna TuomelaJouko SandholmKatri S. Selander Preclinical study 31 July 2012 Pages: 481 - 493
Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor Fathima R. KonaKarri StarkQ. Ping Dou Preclinical Study 01 August 2012 Pages: 495 - 503
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib Anneleen DaemenDenise M. WolfLaura J. van’t Veer Preclinical study Open access 09 August 2012 Pages: 505 - 517
MMP-9 increases HER2/neu expression and alters apoptosis levels in human mammary epithelial cells (HMEC) Matilda FatunmbiJustin SheltonSusan M. Aronica Preclinical Study 10 August 2012 Pages: 519 - 530
TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy Jiayu WangBinghe XuYing Fan Clinical Trial 03 August 2012 Pages: 531 - 537
Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancer Steven D. HeysKeith N. StewartAndrew J. Rees Clinical Trial 11 August 2012 Pages: 539 - 548
Regular screening mammography before the diagnosis of breast cancer reduces black:white breast cancer differences and modifies negative biological prognostic factors Paula GrablerDanielle DupuyDavid Ansell Clinical trial 12 August 2012 Pages: 549 - 553
Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women A. J. AgboolaA. A. MusaI. O. Ellis Epidemiology 29 July 2012 Pages: 555 - 569
Mammographic density and breast cancer risk in White and African American Women Hilda RazzaghiMelissa A. TroesterRobert C. Millikan Epidemiology 03 August 2012 Pages: 571 - 580
Preventing weight gain during adjuvant chemotherapy for breast cancer: a dietary intervention study A. VillariniP. PasanisiF. Berrino Epidemiology 08 August 2012 Pages: 581 - 589
Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system Marilyn L. KwanLing ShenSaskia R. J. Thiadens Epidemiology 19 August 2012 Pages: 591 - 602
Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case–control study Isabelle Le RaySophie Dell’AnielloSamy Suissa Epidemiology 19 August 2012 Pages: 603 - 609
Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women’s Health Initiative observational study Christopher I. LiJustin E. MirusPaul D. Lampe Epidemiology 19 August 2012 Pages: 611 - 618
Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer Y. DelpechY. WuL. Pusztai Brief Report 14 August 2012 Pages: 619 - 627
